Survey: Companies Look To Novel Therapeutic Modalities For Growth
This article was originally published in The Pink Sheet Daily
Executive Summary
A broad cross section of the biopharmaceutical industry is concerned about managing the regulatory process in the geographies where they already conduct business, followed by political issues and reimbursement issues.